Beta-adrenergic receptor blockers improve survival in patients with advanced non-small cell lung cancer combined with hypertension undergoing radiotherapy

Abstract Hypertension (HTN) is prevalent in non-small cell lung cancer (NSCLC) patients, yet the cardioprotective and survival benefits of β-adrenergic blockers during radiotherapy (RT) remain underexplored. We analyzed data from a Chinese clinical cohort of 750 patients with stage IIIA to IIIB NSCL...

Full description

Bibliographic Details

Published in:	Scientific Reports
Main Authors:	Xinyi Liang, Pengwei Li, Yiwei Qin, You Mo, Dawei Chen
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-03-01
Subjects:	β-adrenergic receptor blockers Hypertension Radiotherapy Non-small cell lung cancer Overall survival Progression-free survival
Online Access:	https://doi.org/10.1038/s41598-025-93205-z